Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Title Grant Type Focus Area Country Application Due Date 2023 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA Advances in the Management of Ulcerative Colitis (UC)Release Date:Education Inflammation & Immunology USA Knowledge Gaps in Managing High-Risk Patients and COVID-19Release Date:Education Hospital USA 2023 Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada; EMD SeronoQuality Improvement Oncology Canada Relapsed/Refractory Multiple Myeloma (North America and Europe)Release Date:Education Oncology All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin AmericaRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology All Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)Release Date:Research Rare Disease All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA Improving the Care of Patients Living with Metastatic Breast Cancer (mBC)Release Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada REI: Advisory Group for Patient-Reported Outcome Implementation in Vulnerable and Underserved PopulationsQuality Improvement Oncology USA Improving the quality of care of patients with urothelial cancerQuality Improvement Oncology Italy Mental Health in RheumatologyRelease Date:Quality Improvement Inflammation & Immunology Canada